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1. Introduction 
Stem cells possess the unique ability to either propagate by self-renewal or to differentiate to 
mature tissues under the influence of appropriate molecular cues. This remarkable feature, 
also termed “stem cell potency” has been the focus of both a historical and current research 
spotlight on stem cells, and particularly the potential for human stem cells in regenerative 
medicine and organ transplantation. There are several classes of stem cells, all varying in 
degrees of pluripotency. Depending on the developmental stage from where they originate, 
stem cell potencies range from totipotency (ability to transform into all cell types), 
pluripotency (most cell types), multipotency (many cell types), oligopotency (few cell types) 
to unipotency (one cell type) (Smith, 2001). Among these, embryonic stem cells (ESCs) 
represent the prototypical pluripotent stem cells.  
Embryonic stem cells are localized to the inner cell mass of the developing mammalian 
blastocyst and can give rise to all future cell types and tissues of the organism. Additionally, 
a small population of embryonic stem cells is allocated to the germline (primordial germ 
cells). The evolution of these germline stem cells is different from the remaining cells which 
undergo gastrulation and give rise to the three germ layers (endoderm, mesoderm and 
ectoderm) during development (Ewen & Koopman, 2010). The survival, gonadal migration 
and proper epigenetic programming of primordial germ cells (PGCs) are major, distinct and 
early events that have an impact on future fertility and the successful transmission of 
genetic information from parent to offspring.  
Finally, stem cells found in neonatal tissues, amniotic fluid, cord blood, and adult tissues are 
categorized as adult stem cells and are usually multipotent, oligopotent or unipotent. Adult 
stem cells are clinically important due to the absence of ethical and federal restrictions on 
their use. Furthermore, they are valued for their relative abundance and accessibility in 
somatic tissues. In contrast, human embryonic stem cells have been the focus of substantial 
research and discussion because of their unique potential to differentiate into almost all 
body cell types and tissues and the relative ease with which they are propagated in cell 
culture. The search for an alternative source of pluripotent stem cells other than from 
human embryos is a much sought after goal in the stem cell research community for several 
reasons. First, diversity in stem cells sources should be explored to better understand and 
evaluate their various clinical utilities. Second, immunological matching of stem cells to 
recipients is necessary to avoid rejection in stem cell-based regenerative therapies. Hence, 
the advent of induced pluripotency and nuclear reprogramming strategies have been well 
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received as alternatives to derive human stem cells (Yamanaka & Blau, 2010). Finally, the 
derivation and use of stem cells require adherence to moral, ethical and political guidelines 
that are constantly changing. This chapter will review the formation of the human germline 
from embryonic stem cells and the subsequent derivation of gametes from mouse and 
human pluripotent stem cells, with an emphasis on the male germline.  
1.1 Mouse and human embryonic stem cells 
The first forays into understanding pluripotency in the mammalian embryo began with rather 
simple experiments in which pieces of mouse germ cell tumors known as teratocarcinomas 
were grown in culture and a variety of pluripotent cell types emerged (Solder, 2006). One cell 
type, termed Embryonal Carcinoma Cells (ECCs), produced all three germ layers as well as the 
original tumorigenic cells when isolated and transplanted into host mice. This established for 
the first time the pluripotent nature of embryonic cells. In the mouse pre-implantation embryo, 
embryonic stem cells (mESCs) first form within the inner cell mass (ICM). In studies by Evans 
and Kauffman and others, cells of the ICM were isolated from late blastocysts and grown in 
culture (Evans & Kaufman, 1981; Martin, 1981). These cells proliferated and demonstrated the 
capacity of self-renewal. The subsequent addition of Leukemia Inhibitory Factor (LIF) 
promoted the self-renewal of mESCs in culture by acting through the Stat3 pathway (Ying et 
al., 2008). Further studies showed that the ICM-derived cells could, if reintroduced into an 
embryo lacking an ICM, recolonize and form all three germ layers of the embryo, including the 
germline (Bradley et al., 1984). MESCs are characterized by the strong and persistent 
expression of important pluripotency genes such as Oct4, Sox2, Nanog and Tcf, among others. 
Thus, in mice, the pluripotent nature of cells derived from the inner cells mass was established 
relatively rapidly and easily than in the human. 
In the human, embryonic stem cells (hESCs) are derived in a very similar manner to mouse 
ESCs from explants of the Inner Cell Mass (ICM) of in vitro fertilized blastocysts. Thomson et 
al. first isolated hESCs from pre-implantation human blastocysts and analyzed their 
morphology and expression of pluripotency genes (Thomson et al., 1998). Although they 
express high levels of pluripotency genes, hESCs share a morphology that is more consistent 
with that of early epiblast stem cells of the mouse (mEpiSCs). Specifically, they are “flattened.“ 
In addition, they depend on basic FGF and Activin signaling for self-renewal, possess large 
nuclear to cytoplasmic ratios, and respond less favorably to single cell clonability in contrast to 
mESCs (Vallier et al., 2005, 2009). While the TGFβ/Activin/Nodal signaling pathways are 
undoubtedly important for hESC pluripotency, the molecular mechanisms underlying these 
observations have yet to be explained. Meanwhile, the transcription factors Oct4, Nanog and 
Sox2 are clearly all involved in hESC pluripotency and newer molecules such as the WNTs 
(Wingless-Type MMTV Integration Site Family Members) have been implicated to drive hESC 
self-renewal through canonical signaling pathways (Sato et al., 2004). The functions of Oct4, 
Sox2 and Nanog are regarded as indispensable for hESC self-renewal as their expression 
typically reduces when hESCs differentiate. Finally, hESCs and mESCs are similar in that they 
both express a reportoire of cell surface proteins that distinguish them from other cell types, 
including SSEA-3, SSEA-4, Tra1-60 and Tra1-81, markers that are routinely used for 
characterization of ES and iPS cell lines. 
Despite the fact that mESCs and hESCs are derived from seemingly equivalent epiblast cells 
in the blastocyst, there remains the question of whether hESCs possess as ‘naïve’ a state of 
pluripotency as do mESCs. This is because mESCs in culture behave more like the early 
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mouse epiblast and demonstrate unrestricted potential for differentiation (Hanna & 
Jaenisch, 2010). Meanwhile, hESCs share some properties with mouse epiblast stem cells 
(pluripotency) but may be more restricted than mESCs (Vallier & Pedersen, 2009). This may 
be the case because current hESC derivation methods from ICM could actually select for 
cells in a different developmental stage than that from the mouse ICM (Nichols & Smith, 
2011). Additionally, it has been observed that ESCS and embryonic germ cells (EGCs) share 
several biomarkers making it difficult to distinguish between the embryonic, pluripotent 
cells and primitive germ cells. The intimate relationship that exists between germline and 
embryonic stem cells in mice and humans is critically important to understand in the future, 
and will vastly improve current and future efforts to derive ‘artificial’ gametes.  
1.2 Nuclear reprogramming and induced pluripotency 
A set of landmark studies conducted by Yamanaka and others recently revealed that just 
four factors normally produced in the embryo are sufficient to reprogram differentiated, 
non-embryonic cells into pluripotent stem cells. This important finding bypasses many of 
the ethical issues associated with the use of human embryos, and also evades potential 
problems with immune rejection that might affect patients upon stem cells transplantation. 
The four Yamanaka reprogramming factors, Oct4, Sox2, Klf4 and c-Myc, when introduced 
into differentiated cells in excess amounts, reverses cell fate and by inducing these cells to 
revert back to a progenitor-like or ESC-like state. It is believed that this is a stochastic 
process whose mechanisms lie in the ability of these four transcription factors to induce 
epigenetic restructuring of the genome, thereby enabling expression of previously silenced 
genes (Hanna & Jaenisch, 2010). These artificially created pluripotent stem cells are termed 
induced pluripotent stem cells (iPSCs) and were first described by Takashaki and Yamanaka 
in rats in 2006 (Takahashi & Yamanaka, 2006). The same researchers also demonstrated that 
they could derive iPSCs from adult human cells, a finding subsequently confirmed by others 
(Nakagawa et al., 2008; Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007).   
A major concern with iPS cells is the level of genomic disruption that occurs with viral 
delivery of the reprogramming factors using retroviral or lentiviral vectors.  Theoretically, 
these viral vectors, by integrating randomly into the host genome, may cause chromosomal 
translocations or transform reprogrammed cells into malignant cells. There are now several 
initiatives underway that seek to understand the degree of genome-wide mutations and 
changes in gene function that occur in iPSCs (Panopoulos et al., 2011). The art of generating 
pluripotent cells now involves making iPSCs with reprogramming proteins using 
techniques that both avoid the use of embryos and the downstream hazards of viral vectors. 
Additionally, it is now possible to employ just the reprogramming proteins of these factors 
without the use of viral vectors to create iPSCs (Zhou et al., 2009). Several gene delivery 
systems that have been described include employing excisable polycistronic cassettes 
(Sommer et al., 2010; Somers et al., 2010), piggyBAC introduction (Yusa et al., 2009), 
transfection and/or nucleofection of plasmids (Okita et al., 2008) and most recently, mRNA 
and miRNA delivery (Warren et al., 2010). There is also evidence that small chemicals can be 
used as agents to induce reprogramming in somatic cells (Zhu et al., 2010). Finally, direct 
reprogramming methods wherein cells from one lineage are directly trans-differentiated to 
another lineage (e.g. fibroblast to neural-like lineage) are gaining in popularity. Specifically, 
terminally differentiated cells like skin fibroblasts can be exposed to a cocktail of factors that 
simultaneously enable reversal of cell fate and induce differentiation to the second lineage 
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(Ieda et al., 2009; Uhlenhaut et al., 2009; Vierbuchen et al., 2010). The use of human, patient-
specific iPSCs in regenerative medicine represents an exciting clinical avenue for the future, 
and will likely find application to human germ cell development. 
1.3 Ethical and technical concerns in the use of stem cells 
Among of the many ethical, technical, and safety concerns associated with the clinical 
application of stem cells, the primary concern surrounds the stem cell source. Human 
embryonic stem cells have generated the most controversy because the procedure of deriving a 
hESC line involves the sacrifice of a donated human embryo, even though the donated 
embryos most likely will be discarded (reviewed in Greely, 2006; Scott & Reijo Pera, 2008). 
Therefore, alternative sources of stem cells, such as iPSCs, which might achieve similar 
therapeutic goals, could be very valuable and bear fewer ethical issues than embryonic stem 
cells. Since one of the standard measures of a pluripotent stem cell is that it reliably forms 
teratomas when transplanted into animal models, careful long-term analysis and follow-up 
after transplantation will be needed in animal models before stem cells or directed 
differentiated cells are applied to humans. Yet, hESCs still represent the best model system 
with which to study early human development because of their differentiation potential and 
epigenetic programming and therefore remain the standard for studying stem cells properties. 
However, their suitability for transplantation studies is questionable mainly because of the risk 
of immune rejection from host human tissues (Swijnenburg et al., 2008). In contrast, patient-
autologous iPSCs are considered more suitable for clinical transplantation due to better 
immunological suitability, but their differentiation profiles, epigenetic status, and potential for 
tumor formation are far less well characterized than are hESCs (Hyun et al., 2007). Therefore, it 
is imperative that studies with hESCs continue to allow better definition of the true potential of 
all other stem cell sources, including human iPSCs. Fortunately, there is currently considerable 
research devoted to deciphering the molecular mechanisms that underlie the cell fate 
reprogramming process. In parallel, many laboratories are now developing iPSC-based 
disease models for human degenerative diseases and cancers. These in vitro studies should 
provide the research community with insight into the mechanisms of disease progression and 
illuminate avenues of therapeutic potential.  Consequently, hESCs will likely remain the “gold 
standard” stem cell type for developing basic scientific and clinical therapeutic protocols, and 
to which iPSCs and adult stem cells will be carefully compared for their therapeutic potential.   
2. Mammalian germline formation  
2.1 Primordial germ cell specification and candidate genes controlling germline 
establishment 
The establishment of early germ cells and their successful maturation are complex processes, 
and require frequent changes in physiology, location and transcriptional profile of involved 
cells. Germline establishment in mammals occurs via “inductive” signaling, in contrast to 
lower organisms such as flies and worms where the germ cell identity is transmitted via the 
inheritance of germ “plasm” (McLaren, 1999, 2000; Saitou et al., 2002). In rodents and 
humans, the first glimpses of primordial germ cell (PGC) formation are observed in the 
embryo after implantation and gastrulation, when the epiblast, endoderm, mesoderm and 
ectoderm are first established (Matsui & Okamura, 2005). At this time, in response to 
molecular cues including Bone Morphogenetic Proteins (BMP4 and BMP8a) from the yolk 
sac, a population of pluripotent stem cells is segregated from the ICM and set physically 
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apart from the extra-embryonic ectoderm or yolk sac of the embryo (Figure 1)  (Lawson et 
al., 1999; Ying 2000, 2001). While BMPs provide the inductive signal to epiblast stem cells to 
supply PGCs, it is not clear what signals control the size of the PGC founder population or 
what molecules signal the termination of PGC specification. BMPs are crucial to 
specification of PGCs due to their activation of the ALK2 receptor and Smad-1/5 signaling 
pathways, as evidenced in mice (Hayashi et al., 2002). In the human embryo, the effects of 
BMPs on germline specification are unclear because there is very limited access to early 
embryonic samples. From work in our laboratory, it appears that similar BMP protein 
pathways are activated in the human embryo during gastrulation that direct PGC 
specification (Clark & Reijo Pera, 2006, Kee et al, 2006).  
Additional mechanisms that may assist germline specification are the activation of 
pathways that either promote PGC survival and/or inhibit molecules that promote somatic 
differentiation of PGCs (Ewen & Koopman, 2010). As such, mouse and human PGCs retain 
expression of several biomarkers of pluripotency, including Oct4, Nanog and Sox2 which 
underlies their close resemblance to other pluripotent stem cells  (Clark & Reijo Pera, 2006; 
Medrano et al., 2010; Nicholas et al., 2009). Interestingly, the transcription factor Sox2 is 
expressed on both mouse and human embryonic stem cells but unlike in the mouse, human 
Sox2 expression is diminished when PGCs migrate to the fetal gonad (Perrett et al., 2008). 
Coincident with the timing of germline specification in the mouse (E7.5), PGCs near the 
extraembryonic ectoderm begin to express germ-cell specific markers such as Blimp-1 
(Prdm1 in human), Stella (Dppa3 in human), E-Cadherin, and Dazl and harbor alkaline 
phosphatase activity. Blimp-1/Prdm-1 is a transcriptional repressor whose activity is 
restricted to the germ lineage and appears to be critical for maintaining a PGC fate. There is 
strong evidence to suggest that in the mouse, Blimp-1 actively represses the somatic fate of 
PGCs by inhibiting expression of key somatic regulators during development (Ohinata et 
al., 2005; Hayashi et al., 2007). It is unclear whether Prdm-1 carries out a similar function in 
human germline formation. Once cell-cell communication has been established, the Fragilis 
(IFITIM-1 in human) and Stella/ Dppa3 genes promote further development of PGCs and 
may do so in a similar fashion as Blimp-1 in mice (Saitou et al., 2002).  
Migration of germ cells to the gonad begins at E8.5 in the mouse and during weeks 4 to 6 of 
human gestation (first trimester). At this stage, PGCs accumulating at the base of the 
allantois exit the extraembryonic ectoderm and begin migration to the developing gonads, 
also known as the genital ridge. During migration, PGCs also proliferate by undergoing 
mitosis and express a new set of biomarkers, including the CXCR4 receptor in mice and the 
proto-oncogene c-KIT and its ligand, KIT in both mice and humans (Molyneaux & Wylie, 
2004; Gomperts et al., 1994). The DAZ gene homologue, DAZL is also expressed on 
migrating PGCs. In the mouse, migratory PGCs display pseudopodia that may assist in 
movement through the hindgut and it is plausible that human germ cells behave similarly 
since they are also observed in the hindgut during migration. Various somatic tissues 
interact with PGCs during the migratory path to the gonad. It is likely therefore, that these 
tissues express molecules and factors that guide or “cue” the PGCs and help maintain their 
survival. In the mouse, several candidate molecules have been identified, including 
receptors such as β-1 Integrin and extracellular matrix components such as Collagen I 
(Chuva de Sousa Lopes et al., 2005; De Felici et al., 2005). Although migration of PGCs is less 
well understood in human development, germ cells have been histologically observed 
during the late first trimester, when they undergo migration to the hindgut (Fujimoto et al., 
1977; Gaskell et al., 2004; Goto et al., 2004). Male and female PGCs have been isolated from 
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Fig. 1. Developmental Cycle of Mammalian Germ Cells.  
Life cycle of the mouse and human embryo following fertilization, progressing through 
gastrulation and producing the germline. The germline develops in the gonads and 
transmits genetic information to the next generation, thus completing the cycle. Fertilization 
of oocytes by sperm promotes the formation of a 1-cell zygote that undergoes cell division 
and cleavage to form a blastocyst. The outer layer of blastocyst gives rise to the 
trophectoderm while the inner cell mass (ICM) contains embryonic stem cells (ESCs). 
During gastrulation (E7.5 in mouse; Day 15+ in human), the blastocyst cavitates and 
develops the three germ layers and the epiblast. The primordial germ cells (PGCs) are 
specified and localize near the extra-embryonic ectoderm, at the base of the allantois. Once 
PGCs are specified, they migrate to the fetal gonads and undergo sex-specific 
developmental to male and female gonocytes. Subsequently, male gonocytes undergo 
spermatogenesis while female gonocytes enter meiotic prophase I and begin oogenesis. 
Adapted from Schuh-Huerta et al., 2011. 
10-week old fetuses and were observed to express Alkaline Phosphatase (AP), a marker of 
PGCs (Goto et al., 2004). The morphology of human PGCs also resemble the rounded shape 
of mouse PGCs. Female-specific germ cells have also been visualized at the ultrastructural 
level during gonadal development in human fetuses (Motta et al., 1997). Finally, recent 
studies by Kerr et al. with human fetal gonads (testis and ovary) provide a detailed analysis 
of pluripotency and germ cell-specific markers. The germ cells of the fetal testis are Oct4 
+/Nanog +/ c-Kit+ from week 7 to 15 after which these cells become localized to the testis 
periphery. Meanwhile, the presumptive gonocytes in the week 15 testis show strong 
expression of Pumilio2 (PUM2), VASA and DAZL and express low to no pluripotency 
markers (Oct4, Nanog, c-Kit, Tra1-60, Tra1-81) (Kerr et al., 2007). In the human fetal ovary, 
as in the testis, the expression of pluripotency markers peaks by week 8 and then declines 
after week 9, as oocytes enter meiosis (Kerr et al., 2008). Interestingly, the cell surface 
markers SSEA-1 and SSEA-4 are co-expressed on the female germ cells from week 5 
onwards although only SSEA-1 is restricted to the germ cell lineage.  
Upon arrival at the genital ridge, germ cells express another germ-cell specific marker, 
VASA, a cytoplasmic protein that is implicated in translational regulation. The gene 
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encoding VASA expression, DDX4 (Mvh in mouse) is highly conserved among species and 
is expressed exclusively in both male and female pre-meiotic germ cells (Gustafson & 
Wessel, 2010). This finding underlines the importance of the VASA protein in germline 
function and makes it an attractive candidate for further study. Along with VASA, other 
factors produced are germ cell nuclear antigen-1 (GCNA-1) and E-cadherin. The sex-specific 
character of the developing gonad is controlled by the chromosomal constitution of gonadal 
somatic cells. In particular, the SRY gene expressed on the Y chromosome in mammals is 
thought to be an essential regulator of various downstream targets including the Sox9 gene 
that controls male gonadal development (McLaren, 1995, 2003). Once within the gonad, 
germ cells associate with Sertoli cells to form testis cords and this interaction induces the 
expression of VASA in post-migratory PGCs. VASA expression is induced in both male and 
female PGCs and persists until these cells enter meiosis and after which its levels diminish 
(Castrillon et al., 2000; Toyooka et al., 2000).  
During germline development, an extensive remodeling of the epigenetic landscape occurs. 
This takes place during embryogenesis and during PGC migration to the gonad (Nicholas et 
al, 2009). The first wave of epigenetic remodeling occurs during implantation of the 
blastocyst and involves the erasure of all DNA methylation at CpG islands except those at 
imprinted gene loci. This transition is observed in all cells of the embryo, including the 
primitive germline. In female PGCs, there is another level of epigenetic change in the form 
of random X inactivation wherein one copy of the X chromosome pair is silenced. The 
second wave of epigenetic remodeling occurs when PGCs migrate to the primitive gonads 
and their paternal or maternal imprinted loci undergo a gradual process of erasure (Hajkova 
et al., 2002; Yamazaki et al., 2003). This phase occurs only in germ cells and may help to 
prime them for sex-specific DNA remethylation, when their developmental programs are 
established (Durcova-Hills et al., 2006). In the mouse, the re-establishment of imprints takes 
place prior to birth in the male prospermatogonia (E15) and only after birth in oocytes 
(Lucifero et al., 2002). In addition to DNA methylation changes, male and female germ cells 
also undergo post-translational histone modifications and RNA-mediated silencing 
(Reviewed in Tasler, 2009 & Nicolas et al., 2009).  
The successful passage of germ cells through meiosis is a unique and highly rigorous 
process. However, between male and female embryos, the timing of meiosis is different. 
Male germ cells are restricted from entering meiosis while female germ cells enter meiosis 
within the embryo. Although the mechanisms for these contrasting behaviors are unclear, it 
appears that the gonadal cells provide the signal for (or against) meiotic entry (Brennan & 
Capel, 2004; Ewen & Koopman, 2010). One signal could be retinoic acid (RA) produced in 
the fetal ovary, which in turn induces Stra8, a key regulator of meiotic entry. In female germ 
cells destined to become oocytes, mitotic divisions cease and meiotic prophase begins with 
the correct stimuli (Borum, 1961); eventually oocytes arrest during Meiosis I prior to fetal 
birth and will only resume meiosis upon receiving hormonal signals during adulthood 
(Peters, 1970). Meanwhile, male germ cells transition from primordial status to the gonocyte 
stage, stop proliferating and remain quiescent in the fetal seminiferous tubules until after 
birth. The post-natal gonocytes then commit to a spermatogonial stem cell (SSC) fate and 
amplify through self-renewal or enter meiosis to initiate spermatogenesis. In both male and 
female germ cells, the synaptonemal complex proteins (SCPs) SCP-1, SCP-2 and SCP-3 are 
critical components of the meiotic machinery during chromosomal segregation (Chuma et 
al., 2001; Parra et al., 2004; Yuan et al., 2000). The completion of meiosis signals that germ 
cells have matured into haploid male and female gametes. At this stage, oocytes exclusively 
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express GDF9 and spermatocytes express TEKT1. However, one feature that distinguishes 
human and mouse germline differentiation is the synchronization of meiotic entry, as in 
human fetal gonads, one can observe both pre-meiotic and meiotic germ cells in close 
proximity (Anderson, 2007).     
Significant efforts have been made to culture mouse and human PGCs and gonocyes in vitro. 
In the case of mouse germ cells, the addition of endogenous factors known to affect germ 
cell development such as BMPs, RA, LIF and Forskolin have produced mixed results in 
maintaining PGCs in culture. For example, adding LIF enhanced PGC survival but the 
observations with the use of other factors not as clear. PGCs may also behave erratically in 
culture (showing low survival rates and non sex-specific behavior) because of the lack of a 
normal somatic environment (Childs et al., 2008). Studies of PGCs by Shamblott et al., 
Turnpenny et al. and Tu et al. with fetal human gonocytes resulted in a mixture of cellular 
phenotypes. Some gonocytes appeared rounded while others took on an elongated or 
‘spindly’ appearance. In addition, they appeared to have different proliferation rates 
(Shamblott et al., 1998; Turnpenny et al., 2003; Tu et al., 2007). Currently, it is not at all clear 
that these cells resemble their germ cell counterparts in vivo, but improvements in culture 
conditions and the cellular microenvironment will certainly help in this regard. 
2.2 Spermatogenesis and early oogenesis 
As delineated earlier, mammalian germ cells populate the testis and ovary during 
development in a incredibly dynamic manner. During early prenatal mice and human embryo 
development, PGCs migrate to the primitive gonad (gonadal ridge) and associate with Sertoli 
cells to form primitive testicular cords (Brennan et al., 2004). Within the testicular cords, the 
primitive germline stem cells (now termed gonocytes) remain in the testis as the gonad 
differentiates. Eventually, Sertoli cells, peritubular myoid cells and gonocytes form more 
compact structures known as the seminiferous tubules. When the gonocytes migrate to the 
periphery of the tubules, they transform into prospermatogonia and then into spermatogonia 
(Gondos & Hobel, 1971). In the fetal testis, prospermatogonia enter mitotic arrest, a feature 
observed at E12.5 to E14.5 in the mouse. At the molecular level, during entry into meiosis, both 
male and female human gonocytes express DAZL proteins and Vasa transcripts and 
downregulate OCT3/4 expression (Anderson et al., 2007). Interestingly, it is the early 
migrating germ cells that share similar properties with embryonic stem cells and testicular 
germ cell tumors (Ezeh et al., 2005). From what is known, the development of gonocytes in the 
fetal ovary follows a similar path in that OCT3/4 expression is reduced while VASA, Germ 
Cell Nuclear Antigen (GCNA) and DAZL are expressed (McLaren, 2003). In contrast to the 
male gonocytes, the female gonocytes receive sex-specific signals from the fetal gonad to enter 
meiotic prophase. After initiating meiosis, the female gonocytes will develop into primordial 
follicles and subsequently into primary follicles at puberty. A key difference between mouse 
and human systems is the timing of primary follicle formation: the mouse achieves this stage 
at birth while in the human ovary, this occurs at puberty (Bukovsky et al., 2005). There is some 
speculation whether this difference in follicle development is due to autocrine signals 
produced from the oocyte itself or from the ovarian environment (Hutt & Albertini, 2007). A 
plausible hypothesis is that the immediate environment of early germ cells determines 
whether they are commit to spermatogenesis or oogenesis. The most obvious source of signals 
are the mesonephros, primitive Sertoli cells in the testis, and primitive Granulosa cells in the 
ovary.     
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Fig. 2. Timeline of Germline Specification and Germ Cell Marker Expression. A temporal 
representation of the stages of human and mouse germline differentiation in vivo. At each 
cellular stage, important molecular and somatic signals controlling that stage are indicated 
above the diagram. Specific germ cell molecular markers are indicated on left with arrows 
depicting the duration of development during which they expression has been observed. 
Genes that are italicized are present in both mouse and human germ cells. At the bottom, an 
approximate timing of each stage during mouse or human germline development is 
indicated. Adapted from Schuh-Huerta & Reijo Pera, 2011. 
 The seminiferous tubule serves as the sperm production center, where approximately 123 x 
106 spermatozoa are produced from germ cells daily, or about 1000 sperm/second (Amann 
et al., 1980; Rooij, 2009). Developing germ cells are arranged along the basement membrane 
in a highly ordered sequence and extend into the lumen of the tubule. At the most basal 
portion of the tubules lies the spermatogonial stem cell (SSC) population, closely associated 
with the adjacent Sertoli cells. Morphologic analysis of the various germ cells reveals at least 
13 recognizable germ cell types in the human testis (Heller & Clermont, 1963, 1964). Each 
cell type is thought to represent a different step in spermatogenesis. From the least to the 
most differentiated, they have been named dark type A spermatogonia (Ad); pale type A 
spermatogonia (Ap); type B spermatogonia (B); preleptotene (R), leptotene (L), zygotene (z) 
and pachytene primary spermatocytes (p); secondary spermatocytes (II); and Sa, Sb, Sc, Sd1, 
and Sd2 spermatids (Figure 3). The early, type A spermatogonia are the most interesting 
germ cell type from a stem cell point of view (Rooij, 2009). In fact, time-course studies using 
GFP-based reporters with early type A, type Ad and type Ap spermatogonia in the mouse 
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revealed that the early type A cell has the ability to divide, self-renew, and give rise to the 
Ad and Ap sun-populations (Nakagawa T. et al., 2007). These observations provide 
evidence for the existence of SSCs in the testis and their clonal behavior is protypical of 
other adult stem cells. 
It is currently thought that pale type A (Ap) spermatogonia in the basal, stem cell niche of 
the seminiferous tubule divide at 16-day intervals and differentiate to type B spermatogonia, 
which then become spermatocytes (Clermont, 1972). The ability of SSCs within the testis 
stem cell niche to undergo stem cell renewal is governed by several known factors. The 
growth factor-receptor kit ligand/c-kit receptor system and the niche factor glial cell line-
derived neurotrophic factor (GDNF) are important in this process (Oatley & Brinster, 2008). 
In fact, spermatogenesis in the rat is dependent on c-Kit receptor activity, whereas 
spermatogonial stem cell renewal may be c-kit independent (Dym, 1994). GDNF appears to 
provide a significant stimulus to self-renewal of SSCs through receptors for GDNF on SSCs 
such as c-Ret and GFR-1(Meng et al., 2000). Despite this, our knowledge of other receptor-
ligand systems that control human SSC renewal is limited at this point. During 
spermatogenesis, the cytoplasm between spermatogonial daughter cells remains conjoined 
after mitosis, forming cytoplasmic bridges between adjacent cells (Ewing et al., 1980). 
Cytoplasmic bridges are thought to be important for synchronized cellular proliferation, 
differentiation, and possibly regulation of gene expression. Thus, SSCs and early 
spermatogonia in the adult testis are critical for germ cell renewal and differentiation into 
sperm and raise important questions about the source of proliferative and differentiation 
signals for spermatogenesis. The majority of stages in mouse spermatogenesis delineated 
above are translatable to the human germ cell development pathway except for differences 
in the timing of each stage during development.   
                   
 
Fig. 3. Cells of the Human Germ Line Sequence. See text for details. With permission from 
Kee et al, 2009. 
3. Germline stem cells 
Under the premise that male and female gametes must be replenished, several investigators 
have queried the existence of elusive germline stem cells. Additionally, the pluripotency 
potential of embryonic germ cells and their similarity to mESCs has fueled the speculation 
about the existence of spermatogonial stem cells and their true differentiation potential both 
in vivo and in vitro. There is compelling data proving the existence and plasticity of testicular 
germline stem cells in the mouse and more recently the human testis. The exploration of 
germline stem cells in the human ovary has been confusing because of findings that 
challenged the long-held notion that females are endowed with a finite supply of oocytes. 
For instance, Johnson and colleagues observed that a small population of germline stem 
cells (GSCs) reside in the ovarian surface epithelium in the mouse and can undergo self 
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renewal of the follicular pool within 24 hours (Johnson et al., 2004). However, these results 
have not been corroborated (Telfer et al., 2005). Johnson et al. reported that bone marrow 
stem cells enter the ovarian follicular pool through the vasculature and could provide a 
source for ovarian stem cells (Johnson et al., 2005). Despite the proof of successful 
transplantation in this study, they failed to demonstrate meiosis in the oocytes generated 
from ovarian stem cells or bone marrow-derived stem cells (Telfer et al., 2005). Furthermore, 
it was not clear whether these ovarian stem cell-derived oocytes could be artificially 
fertilized. Based on these findings, the existence of germline stem cells in the adult ovary 
remains unknown.   
3.1 Testicular stem cells in animal models 
Evidence for stem cells in the adult testis was first provided by Brinster and colleagues in 
1994 when they transplanted a putative SSC population into mice and observed complete 
spermatogenesis with transplanted cells (Brinster RL & Zimmermann JW, 1994). Recent 
research has sought to characterize the true stem cell potential of early spermatogonia 
within the seminiferous tubule. Kanatsu-Shinohara et al first reported the generation of 
pluripotent stem cells from the mouse testis (Kanatsu-Shinohara et al., 2004). In their study, 
a population of cells termed germ line stem cells (GSCs) were isolated from neonatal mouse 
testis and propagated in culture (Kanatsu-Shinohara et al., 2003). Subsequently, they found 
that cell colonies with morphology quite distinct from GSCs, termed ESC-like cells, also 
appeared in culture. The formation of both GSCs and ESC-like cells depended on a GDNF 
signal and only ES-like cells expanded in regular mESC media. The expression profile and 
imprinting profiles indicated that the ES-like cells were more like ESC than GSCs. The 
definitive test of pluripotency or multipotency in stem cells is to transplant them and assess 
their ability to form all three germinal layers. In the case of spermatogonial stem cells or 
their transformed cell types, the ability to form germinal layers and sperm was tested 
following transplantation. Interestingly, transplantation of ESC-like cells into seminiferous 
tubules gave rise to teratomas while GSC transplants led to spermatogenesis without 
teratomas. When ESC-like cells were transplanted via subcutaneous delivery, teratomas 
containing all three germ layers formed. These ESC-like cells also had the potential to 
develop into various other cell types, including mature germ cells, showed chimera 
formation and germ line transmission. More recently, a study by Simon et al. revealed that 
when putative mouse SSCs were recombined with organs of fetal or neonatal origin, these 
cells had the ability to transdifferentiate into cells of all three germ layers as well as uterine, 
prostatic and skin epithelia (Simon et al., 2009). Thus, these experiments in rodents reveal 
that GSCs and ESC-like cells have very different stem cell characteristics. Unlike with 
neonatal testis, the authors were unable to generate ESC-like cells from adult mouse adult 
testis.  
A major finding was reported in 2006 by Guan et al. wherein they successfully derived 
pluripotent stem cells from the adult mouse testis (Guan et al., 2006). With the introduction 
of a Stra8-eGFP reporter in which GFP expression was regulated by Stra8 promoter activity, 
ES-like cells were separated from a heterogenous population of testicular cells. When these 
isolated ES-like cells were grown on mouse embryonic fibroblasts or cultured in medium 
containing LIF, they evolved into a subpopulation of cells that the authors termed 
multipotent adult germline stem cells (maGSCs). The pluripotency potential of maGSCs was 
verified by RT-PCR, in vitro differentiation to all three somatic germ layers, and by 
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successful teratoma formation in vivo. Another transplantation study by Nakagawa et al. in 
2007 employed the Neurog3 (Ngn3) promoter to induce GFP expression and thereby enrich 
for two populations of undifferentiated spermatogonia (Nakagawa T. et al., 2007). The 
researchers took advantage of the expression of NGN3 on undifferentiated spermatogonia 
and, from their sorting studies, the first population of cells maintained the SSC progenitor 
pool through self-renewal while the second population revealed a pool of SSCs that 
diminished with age. More importantly, the study by Nakagawa and colleagues suggested 
that the population of SSCs in mice testes is ~2000 cells, substantially less than previous 
estimates of ~35000 cells (Nakagawa T. et al., 2007). A population of pluripotent stem cells in 
the adult mouse testis was again confirmed by Ko et al. in 2009. The authors showed that 
GSCs obtained from the adult mouse testis traverse through unipotency before conversion 
into multipotent ESC-like cells (Ko et al., 2009). They concluded that that the number of 
GSCs and culture duration are defining factors in deriving pluripotent stem cells from the 
germline: they termed these cells germline-derived pluripotent stem cells (gPSCs). In 
characteristic fashion of ESC-like cells, gPSCs demonstrated in vitro differentiation to all 
three somatic cell layers, teratoma formation and germ line transmission. Thus, several 
reports have documented the production of multi- or pluripotency germline stem cells in 
the mouse. 
In parallel to these studies of mice multipotent germline stem cells, several groups have 
reported a collection of genes and biomarkers that are non-exclusively expressed by mouse 
SSCs (Reviewed in Caires et al., 2010). These include receptors and downstream facilitators 
of GDNF action such as GFR1 and RET proteins (Naughton et al., 2006). The gene Ngn3 is 
also highly expressed on undifferentiated spermatogonial stem cells (Yoshida et al., 2004).  
The signaling activities of the PI3 Kinase family acting through AKT proteins are also 
important for SSC self-renewal because blocking these pathways suppresses GDNF activity 
and reduces spermatogenesis in mice (Oatley et al., 2006). Other molecules expressed on 
SSCs are Oct4, Bclb6, Etv5, Lhx1 and Nanos2 (Caires et al., 2010). In the future, we hope to 
employ these markers to more accurately isolate and definitively characterize putative SSC-
like cells.  
3.2 Testicular stem cells in the human 
Based on the success in the adult rodent testes, several investigators have attempted the 
same types of studies in the human. In a landmark study, Conrad and colleagues devised a 
method by which they could harvest adult spermatogonial stem cells and subsequently 
reprogram them into pluripotent cells (Conrad et al., 2008). They employed the use of adult 
testis tissue from which they harvested a mixed cell population. The single cell suspension 
was then cultured in vitro in the presence of GDNF, as mouse studies have shown this 
growth factor to be critical for self-renewal of SSCs. They then purified SSCs by magnetic-
activated cell separation (MACS) with CD49f bound beads. Further selection on collagen 
and laminin plates led to a highly enriched population of spermatogonial cells. When 
cultured in the same media used for hESCs and supplemented with LIF, the spermatogonial 
cells gradually arranged in multilayered, clustered colonies and displayed features 
consistent with pluripotent stem cells. The researchers termed these cells human adult 
germline stem cell (haGSC). Extensive characterization of haGSCs was then carried out by 
analyzing gene and protein expression and conducting microarray analysis for genome-
wide changes in expression. Epigenetic reprogramming was assessed and various 
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pluripotency markers were measured. Finally, the cells were karyotyped and a teratoma 
formation assay was successful in immunodeficient mice (Conrad et al., 2008). Overall, the 
authors observed significantly different expression profiles in haGCSs compared to the 
parent spermatogonial cells, and haGSCs acquired expression profiles similar to hESCs. 
Although a complete analysis of a novel cell population in the human testis, several caveats 
to this research exist. Entire testicles were used to derive spermatogonial cells, bringing into 
question the feasibility of this approach for clinical use (Kee et al., 2010). In addition, the 
global gene expression patterns of plurpotency markers obtained from these haGSCs have 
been challenged as being more closely associated with fibroblasts than hESCs (Ko et al, 
2010). Nevertheless, the above experiments underline the concept that adult germline stem 
cells and by extension PGCs may share basic properties with hESCs. 
To address the issue of limited availability of starting material, an alternative protocol for 
generating human pluripotent stem cells was reported by Kossack et al., 2009. Their 
approach required only a testis biopsy as starting substrate. The biopsies were 
enzymatically digested and testicular cells released in suspension were grown in basic 
media until small colonies of cells began to form. Selection for cells in colonies was 
performed by manually dissecting out colonies and then propagation on mouse embryonic 
fibroblasts (MEFs) in hESC culture conditions, supplemented with bFGF. Under these 
conditions, the spermatogonial cells acquired a hESC-like morphology and physical 
characteristics, and were termed human multipotent adult germline stem cells (hMGSCs). 
Careful analysis revealed that hMGSCs were karyotypically nomal, expressed both 
pluripotency and early germ cell markers and contained a generally hypomethylated DNA 
pattern consistent with hESCs rather than somatic cells. Albeit spontaneously differentiating 
to cells of endodermal, mesodermal, and ectodermal lineages, hMGSCs did not successfully 
form teratomas in vivo. Therefore, despite a simpler methodology using limited substrate, 
this study suggested that hMGSCs, unlike true hESCs, might be only multipotent and not 
fully pluripotent. A third study also used testicular tissue fragments as a cell source from 
which to separate spermatogonial stem cells (Golestaneh et al., 2009). Using 1g of testicular 
tissue, much larger than routine testis biopsy, they also derived pluripotent stem cells after 
isolated seminiferous tubules were enzymatically digested and grown in hESC media 
(supplemented with bFGF and TGF-β but not grown on MEF feeders). After several 
passages, they observed medium-sized colonies of ~500 cells which were termed ESC-like 
cells. As expected, these cells expressed pluripotency markers and they were able to 
differentiate to endoderm, mesoderm, and ectoderm. Similar to the finding of Kossack et al, 
only small teratomas formed from the transplanted ES-like cells, and only when large cell 
numbers (~2x106) were used. Thus, this study also suggests that the pluripotency of these 
ES-like cells may not be identical to true hESCs.  
As eluded to above, a major limitation of deriving SSCs is the requirement for generous 
amounts of human testicular tissue as starting substrate. Protocols need to be refined to 
allow pluripotent stem cell generation from the smallest amount of testis tissue substrate to 
make this technology feasible for clinical use. Another limitation is the low efficiency of 
isolating SSCs from testis tissue and of generating pluripotent stem cells from SSCs. 
Optimization of culture conditions may reduce these inefficiencies in the future. Despite 
this, research over the last decade has uniquely highlighted the stem cell potential of SSCs 
derived from the human testis and their remarkable similarity to the differentiation 
potential of ESCs. A major drawback has been the inability of the SSCs to consistently 
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produce large teratomas. This likely indicates that SSCs are only multipotent and not 
pluripotent (Kee et al., 2009), a distinction that has implications for the therapeutic potential 
of SSCs. Will they only be useful for obtaining sperm or will they have a broader potential 
for cell-based therapies in unrelated target tissues? Finally, the relatively invasive procedure 
for isolation of adult human germline stem cells from the testis compared to derivation of 
iPSCs may favor the latter approach as a preferred methodology for clinical use.    
3.3 Azoospermia and genetic control of spermatogenesis 
Human infertility is remarkably common, affecting 10-15% of couples. Most commonly, 
infertility is caused by defects in germ cell development (de Kretser, 1997; Skakkebaek et 
al., 1994). Microdeletions in the AZF (Azoospermia Factor) region of the human Y 
chromosome are the most common cause of human infertility and Non-Obstructive 
Azoospermia (NOA) in men. The associated clinical phenotypes are typically 
azoospermia or severe oligospermia, and on diagnostic testis biopsy reveal the complete 
absence of the germ cell lineage, to maturation arrest of spermatogenesis, to the 
production of a small number of germ cells (Gonzalves et al., 2005). The AZF region is 
highly repetitive and consists of numerous palindromic regions thought to have arisen 
out of repeated rounds of gene duplication and inversion (Kuroda-Kawaguchi et al., 2001; 
Skaletsky et al., 2003). The highly repetitive nature of the AZF region makes it particularly 
prone to homologous recombination between direct repeats and resulting in deletions. 
There is now a fairly comprehensive chromosomal map of the AZF regions with three 
specific regions currently identified, AZFa, AZFb and AZFc, that represent multi-gene 
segments on the Y chromosome (Kuroda-Kawaguchi et al., 2001).  The most commonly 
deleted of these three is the AZFc region, resulting in phenotypes that range from 
complete absence of the germ cell lineage (termed Sertoli Cell Only [SCO] syndrome) to 
oligospermia (Reijo Pera, 1995, 1996). In spite of their deletion frequency, the function of 
genes that map to the Y chromosome AZFc are still poorly understood. This region 
harbors six multi-gene families including the RBMY, PRY, VCY2, CDY1 and DAZ genes 
(Kuroda-Kawaguchi et al., 2001). Intriguingly, all of the protein-coding AZF genes are 
expressed exclusively in germ cells and some testicular cells, suggesting their importance 
in germ cell development (Navarro-Costa et al., 2010). Although precise functions have 
not been pinpointed, the predicted sequences and protein structures encoded by these 
genes provide a glimpse into their potential function. For instance, DAZ and RBMY genes 
are thought to be involved in RNA binding and transport, thereby positioning them as 
regulators of mRNA translation during spermatogenesis (Collier et al., 2005; Kee et al., 
2009; Lee et al., 2006). Meanwhile, CDY and BPY2 genes are likely regulators of chromatin 
and genome organization (Caron et al., 2003; Lahn et al., 2002). Our overall understanding 
of infertility genetics will be greatly advanced by studying the molecular contribution of 
genes such as DAZ to meiotic recombination, DNA repair, epigenetic reprogramming and 
the development of cancer and other clinical aberrations.  
4. From embryonic stem cells to germ cells 
Our knowledge about mouse embryo and germline development from mESCs has allowed 
for in vivo and in vitro modeling of germline development. However,  very limited access to 
early-stage human embryos and especially primordial human germ cells has greatly 
reduced the ability to conduct similar investigations into human germline development, let 
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alone modelling it in vitro. This section reviews the highlights of experiments conducted 
during the last decade using in vitro model systems of mouse and human germline 
development from mESCs and hESCs (Table 1).  
 
 
Table 1. A Summary of the Recent Efforts to Derive Gametes from ESCs and iPSCs. Note: 
mESC – mouse embryonic stem cells; hESC – human embryonic stem cells; EB – embryoid 
body; BMP – bone morphogenetic protein; Mvh – mouse Vasa homolog; RA – retinoic acid; 
ICSI – intracytoplasmic sperm injection; MEF – mouse embryonic feeders. 
4.1 Derivation of germ cells from mouse and human embryonic stem cells 
The mouse has proven to be a robust and dependable system for analysis of germline 
development. Studies conducted in vivo during mouse early development have greatly 
informed in vitro investigations and have generated promising prospects for creating 
gametes from stem cells. The earliest in vivo evidence for embryonic stem cell-derived germ 
cells was suggested from experiments performed by Bradley et al. in 1984. They generated 
germline chimeras after injecting mESCs into blastocysts (Bradley et al., 1984). This work 
suggests that mESCs, if cultured under the right conditions, could be differentiated to PGCs. 
We now know that mESC share many developmental features and markers with PGCs 
which further supports the use of mESCs as a starting point. This is most convenient as 
mouse PGCs are difficult to grow and differentiate in vitro due to limited viability in culture 
(Resnick et al., 1992; Farini et al., 2005). Thus, we have learned a lot over the two decades 
about mouse embryonic and germ cell development to guide us as we more forward. 
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The first report on the creation of putative germ cells in vitro was reported in 2003. In this 
study, mESCs were transfected with a reporter Green Fluorescent Protein (GFP) under the 
control of an Oct4 enhancer sequence (Hubner et al., 2003). The withdrawal of LIF, a factor 
that promotes self-renewal in mESCs, promoted PGC development and resulted in an 
increase in GFP-positive cells. More importantly, the GFP-positive cells assumed a follicle-
like appearance and showed overall structural and molecular similarities to oocytes. 
Tooyaka et al. used a similar, reporter-based approach to derive male germ cells that 
resembled mouse spermatozoa (Tooyaka et al., 2003). They utilized the mouse VASA 
homologous gene promoter Mvh to drive GFP expression in mESC, which then 
spontaneously differentiated to embryoid bodies (EBs) in the absence of LIF. The putative 
PGC population when transplanted into a mouse neonatal testis, differentiated to give rise 
to spermatozoa.  These two landmark studies set the stage for further investigation of 
deriving gametogenesis from mESC.  
In 2004, Geijsen et al. derived male gametes from EBs after culture in the presence of retinoic 
acid (RA), a key paracrine factor produced in the testis (Geijsen et al., 2004). Additionally, by 
selecting cells that only expressed SSEA-1 and Oct4, the authors were able to enrich for 
mature, post-meiotic germ cells that were then capable of forming blastocytes after injection 
into oocytes. It was later shown by Kerkis et al. that the divergence of male and female germ 
cell programs during spontaneous differentiation of EBs in vitro was dependent on the 
length of culture time (Kerkis et al., 2007).   Several attempts at oocyte or follicle derivation 
from mESC have been made using the EB-based approach with various culture  and 
attachment conditions all of which yielded oocyte-like cells that lacked critical structural 
features such as the zona pellucida or expression of meiotic molecular machinery (Lacham-
Kaplan et al., 2006; Novak et al., 2006). Other studies have employed slightly different 
approaches to derive putative oocytes from mESCs. Qing et al. obtained PGCs from cultured 
EBs and then co-cultured them on a layer of fetal ovarian granulosa cells and observed an 
increase in the meiotic marker SCP3 and upregulation of oocyte-specific genes such as Gdf9. 
The GDF9 positive cells probably resembled an immature oocyte as they lacked a zona 
pellucida and did not express mature oocyte proteins such as ZP4 (Qing et al., 2007). In an 
alternative approach developed by Salvador et al., a Gdf9-driven GFP reporter assay was 
introduced into mESC. The mESCs were then differentiated to EBs and GFP-positive cells 
were isolated from the EBs to isolate PGCs (Salvador et al., 2007). In summary, these studies 
may have derived primitive oocytes from mESCs, but failed to accomplish meiotic entry in 
the final cell products.  
An alternative approach to deriving female germ cells was employed by Nicholas et al. by 
using a germ cell-specific reporter, ΔPE:Oct4: GFP. This reporting system was previously 
employed by Hubner et al. to separate GFP-expressing ESCs, PGCs and primary 
spermatogonia in the mouse (Nicholas et al., 2009). After verifying the expression of GFP on 
these subsets of cells, the authors spontaneously differentiated mESCs carrying this reporter 
to EBs, then FACS-sorted GFP positive cells, and observed a higher expression of germ cell 
and oocyte markers in the selected cells. They then assessed whether ESCs could give rise to 
mature oocytes in vivo by first forming aggregates of the GFP-positive cells with fetal 
ovarian tissue and then transplanting them to the kidney capsule. In doing so, they 
observed mature oocytes of confirmed ESC origin, some of which resembled primordial 
follicles with a surrounding layer of granulosa cells. An important insight from this work 
was that the timing of germline development, particularly with oocyte maturation, is a 
major parameter in deriving gametes. Furthermore, it highlights that the use of 
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transplantation in combination with in vitro culturing may greatly improve the success of 
gamete production from mESCs.             
The first study to show virtually complete gametogenesis in vitro was conducted by 
Nayernia et al. in 2006. A two-stage approach was employed to first derive pre-meiotic 
PGCs from mESCs with a Stra8 driven GFP reporter induced with RA addition (Nayernia et 
al., 2006). GFP-positive cells were then separated by Fluorescence Activated Cell Sorting 
(FACS), grown in RA-supplemented medium and transfected with a second reporter, Prm1-
dsred. The second reporter enriched for PGCs that had undergone meiosis and formed red-
fluorescing, haploid cells. After further RA treatment, the haploid sperm-like cells were then 
injected into mouse oocytes by Intra-Cytoplasmic Sperm Injection (ICSI) to test the 
functionality of the derived germ cells. Indeed, blastocysts formed and viable offspring born 
that eventually succumbed to developmental complications and died prematurely. 
Potentially, the epigenetic reprogramming of the derived germ cells may not have been 
complete. Nevertheless, these efforts provided functional proof of gametogenesis in vitro.  
Additional studies demonstrating in vitro spermatogenesis have employed organ culture 
systems as far back as 1960. Since then, there has been tremendous progress in the study of 
germ cell development, particularly in the mouse. This is best exemplified by a very recent 
study by Sato et al. in which functional mouse sperm were generated in vitro by employing 
a novel organ culture method. Specifically, they improved on existing organ culture 
methods by placing neonatal (mouse pup) testis fragments in FBS-soaked agar plugs in 
culture (Sato et al., 2011). With these plugs, they controlled the gas:liquid interface and also 
added exogenous factors. Their study conclusively showed through an analysis of reporter 
expression before and after meiosis, that functional, haploid spermatozoa were generated 
that could fertilize oocytes and give rise to viable, healthy pups. In addition, the generated 
pups were also shown to be naturally fertile as adults. In summary, attempts to generate 
germ cells from mESCs have yielded cells that resemble sperm or oocytes in gene 
expression, ploidy, epigenetic reprogramming and fertilization ability. However, these 
studies have also revealed inregularities in the duration of meiosis in culture, in the 
morphological features of oocytes, in the viability of offspring generated and in the germline 
transmission of exogenous genes to the offspring (Chuva de Sousa Lopes et al., 2010).    
The evidence for germline differentiation from hESCs is more complex; as such literature is 
more preliminary than that from the mouse. Furthermore, doubts regarding the extent of 
pluripotency in hESCs vs. mESCs and the ethical constraints of testing the functionality of 
human germ cells are legitimate considerations with this research. Despite this, there is a 
tremendous need to understand human germline formation, the genes that control 
spermatogenesis and oogenesis and from a clinical standpoint, a need for in vitro derived 
functional gametes. Efforts to derive human germ cells began with a study by Clark et al. in 
2004 in which spontaneously differentiated hESCs were used to create embryoid bodies 
(EBs) (Clark et al., 2004). Within the EB mixed cell population, they identified the levels of 
several known germ cell markers such as DAZL, STELLAR and c-KIT. Additionally, they 
observed that VASA levels were induced within a putative PGC population and other 
markers of meiosis were also upregulated. Collectively, their data indicated that PGCs had 
formed but had not entered meiosis. An important facet of their study was the identification 
of germline-associated genes such as DAZL and c-KIT as expressed in undifferentiated 
hESCs, which reminds us that hESCs may not be truly equivalent to cells of the ICM (Clark 
et al., 2006). The methods of Clark et al. were optimized in a follow-up study in which BMP-
4, -7 and -8 were added exogenously during EB formation from hESCs and higher VASA 
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expression was observed in the putative PGC population (Kee et al., 2006). Therefore, 
similar to the mouse model, the role of BMPs in human germline specification may be 
important. More recent studies using mESCs in vitro by Young et al. have illustrated how 
BMP2 and BMP4 but not BMP8b are important inductive agents for specifying the germ cell 
lineage in EBs (Young et al., 2010). These results help to clarify our understanding of BMP 
action in the germline as the goal of deriving haploid germ cells is pursued. 
Chen et al. and Tilgner et al. also derived human PGCs from substrate EBs in independent 
studies. They observed that their EBs contained small structures that resembled ovarian 
follicles and that tested positive for c-KIT and low amounts of VASA protein (Chen et al., 
2007). They also observed these structures in hESCs that were spontaneously differentiated 
in adherent cultures, suggesting that EBs are not essential for germ cell differentiation, at 
least in the female lineage. Meanwhile, Tilgner et al. used a more sophisticated strategy to 
separate germ cells from EBs and adherent cultures through FACs sorting for cells 
expressing the surface marker SSEA-1, a protein associated with very early germ cells 
(Tilgner et al., 2008). Despite evidence of complete epigenetic reprogramming in these early 
germ cells, the authors did not observe meiosis. In 2009, Park et al. built upon the findings of 
Tilgner et al. by isolating differentiated cells enriched in SSEA-1 as well as c-KIT expression. 
However, they used an interesting differentiation strategy and co-cultured hESC colonies 
with stromal cells from the human fetal gonad (Park et al., 2009).  In this model, the 
paracrine factors produced from fetal stromal cells would ideally resemble those made in 
vivo, thereby theoretically inducing primitive germ cells to differentiate into PGCs. Their 
efforts were successful, yielding SSEA-1 /c-KIT positive PGCs that expressed numerous 
germ cell markers such as VASA, PRDM1 and DAZL and revealed evidence of partial 
epigenetic reprogramming. 
Based on the findings of spontaneous differentiation of hESCs to PGCs, researchers have 
entertained the possibility that a small population of cells within a typical hESC population 
is pre-destined to become germ cells. Based on this hypothesis, several groups have 
explored whether simply optimizing culture conditions of hESCs can promote or induce 
germline differentiation. Stice and colleagues first reported that by the simple addition of 
basic FGF (bFGF) to hESCs growing on inactivated MEF feeder cells, they could produce 
approximately 69% VASA-positive cells with increases in expression of germline and 
meiotic markers (West et al., 2008). These data seem rather optimistic given that most other 
groups have reported much lower germ cell numbers under similar culture conditions. 
Concurrently, Bucay et al. modified their culture conditions by lowering the confluency of 
hESC colonies and observed a subpopulation of cells expressing CXCR4, a membrane 
receptor implicated in PGC migration (Bucay et al., 2009). Upon purification, the CXCR4-
expressing cells could be grown on a laminin substrate and gave rise to putative PGCs and 
Sertoli cells. In recent studies, West et al. explore the effect of modulating KIT ligand (KIT-L) 
and BMP4 activities in culture of hESCs and observed that these are required for early germ-
like cell (GLC) derivation (West et al., 2010a).  
A major milestone in germline differentiation of both male and female human PGCs is the 
initiation and completion of meiosis. Deriving haploid gametes in vitro is a significant feat 
and one that researchers have struggled with for years in human germline differentiation. 
Kee and colleagues derived human haploid gametes for the first time in 2009 by introducing 
three major genes of the Deleted-in-Azoospermia (DAZ) family, DAZ, DAZL, and BOULE 
in hESCs and then differentiating the cells spontaneously in adherent culture conditions 
(Kee et al., 2009). Although a low number of haploid (1n) cells were observed (~2%) seven 
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days after differentiation, they expressed numerous germ cell-specific markers and meiotic 
spreads indicated the presence of SCP3, a key member of the synaptonemal complex that 
forms during meiosis. These data also reinforce the importance of the DAZ family of genes 
for early (DAZL) and late (BOULE, DAZ) primordial germ cell formation. Since this work 
was published, another group has demonstrated meiosis in in vitro derived PGCs: West et 
al. had previously shown that they could isolate early VASA-positive germ-like cells (GLCs) 
and were able to subclone at least three populations of these cells from their mixed cultures 
and propagate them through at least 50 serial passages (West et al., 2010b). These cells were 
then be differentiated with FBS into a more homogenous population and the majority of 
cells entered meiosis (~71%) while also expressing germline and meiotic markers (West et 
al., 2010b). Taken together, these studies offer alternative and compelling strategies for 
derivation of PGCs from hESCs. While one (West et al., 2010b) suggests that GLCs are a 
natural clonal subpopulation of hESCs that can be propagated in vitro, the other (Kee et al., 
2009) argues in favor of an active, gene-driven induction of germline differentiation.  
4.2 Germline differentiation from human induced pluripotent stem cells  
Ongoing advances in reprogramming of human somatic cell to pluripotent stem cells 
(iPSCs) or direct reprogramming of somatic cells to specific cell lineages, are a legitimate 
avenue for autologous, patient-derived stem cell therapies. By applying similar genetic 
approaches used for human ESCs, iPSCs can now be directed to give rise to cells of the germ 
cell lineage. We summarize here some of the recent efforts in this area. The use of human 
iPSCs (hiPSCs) to derive gametes was first shown by Park et al. in a study that also 
compared the derivation efficiency to hESCs (Park et al., 2009). In short, they grew hiPSCs 
on a feeder layer of fetal gonad stromal cells and subsequently isolated SSEA-1 + / c-KIT + 
cells which they characterized as a putative PGC population. These human induced PGCs 
(hiPGCs) expressed several germline markers but did not show evidence of imprinting 
erasure, a key feature of early PGCs. Further evidence for the creation of haploid hiPGCs 
from male and female hiPSCs was provided by Panula et al. recently wherein they used a 
GFP reporter under the control of the Vasa promoter to select for putative germ cells from 
spontaneously differentiated cultures (Panula et al., 2010). The Vasa-GFP transduced hiPSCs 
were differentiated adherently in feeder-free conditions in the presence of BMPs, giving rise 
to approximately 5% GFP-positive PGCs. These PGCs expressed a number of germ cell 
markers such as Prdm1A, ACTC, Gata6, Pelota and IFITM1. More importantly, the GFP-
positive hiPGCs expressed the meiotic marker SCP3 in both punctate and elongated 
patterns, indicative of early and late meiosis, respectively. Interestingly, when compared to 
PGCs derived from both male or female hESCs, the efficiency of hiPGC derivation appears 
higher, suggesting that hiPSCs may be a better starting substrate for germline 
differentiation. In summary, these two investigations provide encouraging results about the 
ability to use hiPSCs to derive gametes in vitro. Although the differentiation potential of 
hiPSCs may vary greatly from one cell line to another, they appear to have strong potential 
as a genetic model system to study human germ cell development. 
4.3 Clinical need and applications for in vitro-derived gametes 
Currently many men suffer from non-obstructive azoospermia as described earlier that 
results in complete sterility. In addition, in the U.S. alone there are 55,000 childhood cancer 
survivors annually, many of whom were unable to bank sperm before receiving sterilizing 
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treatments. Similarly, women have a finite supply of reproductively competent oocytes 
while others undergo premature ovarian failure, making childbearing difficult or 
impossible. Alternative options for parenthood in these cases are not always simple or 
inexpensive. Although sperm donation is economical, oocyte donation is quite expensive 
and the use of donated embryos is unusual (Nicholas et al., 2009). For men, recent strategies 
  
  
 
Fig. 4. Comparison of in vivo Germline Development and in vitro Germ Cell Derivation from 
ESCs and iPSCs.A depiction of in vivo development of germ cells and gametes from the 
mammalian embryo showing that embryonic stem cells (ESCs) originate from primitive 
ectoderm, by way of the inner cell mass (ICM). Primordial germ cells then migrate to gonads 
where they undergo self-renewal in the form of spermatogonial stem cells (SSCs) in the 
testis and oocytes in the ovary. On the right is a schematic of the cell lineages derived in 
vitro. ESCs cultured in dishes can be differentiated to PGCs via methods summarized in 
Table 1. PGCs cultured in vitro, at least in the mouse, can transform to embryonic germ (EG) 
cells. There is also evidence a subpopulation of hESCs cultured in vitro behave like EG cells. 
Finally, somatic cells can be reprogrammed with addition of Oct4, Sox2, Klf4 and c-Myc 
transcription factors to induce a stem cell-like fate. iPSCs can then be induced to form PGC-
like cells or EG-like cells. Finally, ESCs, PGCs and iPSCs can all form teratomas when 
injected in vivo demonstrating their pluripotency. 
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such as extracting low numbers of testis sperm after prior localization with Fine Needle 
Aspiration (FNA) mapping, offer the hope of fatherhood for some candidates (Beliveau et 
al., 2011; Natali et al., 2011). 
Although such strategies are gaining in popularity, the pregnancy success rates remains at 
about 30-40% using sophisticated in vitro fertilization (IVF) techniques (Centers for 
Disease Control [CDC], 2008). In addition, with these reproductive technologies, there 
remain important safety concerns about de novo sex chromosomal disorders, birth defects 
and imprinting-related disorders such as Beckwith-Wiedeman syndrome in offspring 
(Childs et al., 2008). Therefore, there is an obvious clinical need for high quality, in vitro-
derived gametes. However, the prospect of employing current protocols and reagents to 
derive human gametes from hESCs appears unlikely at this time. On the other hand, the 
use of iPSCs and alternative stem cell sources such as adult stem cells, hold great promise 
in thisregard. In the foreseeable future, patients with genetic disorders affecting fertility 
could theorectially donate somatic cell biopsies that could then be reprogrammed into 
iPSCs and genetically modified to normal and subsequently utilized for gametogenesis in 
vitro. 
However, there are numerous challenges to the application of iPSCs for clinical use (Hanna 
et al., 2010). For one, the exact level of authenticity and experimental proof required for the 
safe use of iPSC and hESC derived gametes in the clinic is entirely unknown. To address this 
issue, there are at least three major areas that the research community can and should 
address before taking in vitro-derived gametes to the clinic. Firstly, the chromosomal 
composition of the iPSCs must be identical to the original patient from where they were 
derived. There is now sufficient data detailing the gene mutations and copy number 
variations arising in iPSCs during reprogramming and clonal expansion. It would be wise to 
carefully screen for these variation in patient-derived samples (Reviewed in Panopoulos et 
al., 2011). Moreover, frequent chromosomal aberrations arise during meiotic recombination 
so it would be necessary to examine the fidelity of meiosis in gametes in vitro. Secondly, it is 
important to check for the proper erasure and subsequent re-establishment of maternal and 
paternal imprints in PGCs derived from both iPSCs and hESCs. There is published work 
with hESCs and iPSCs that has attempted to characterize imprinting status and DNA 
methylation patterns in these derived cells; the preliminary evidence seems to indicate that 
in vitro derived hiPGCs appear to undergo partial to full imprinting erasure (Kee et al., 2009; 
Panula et al., 2010). Whether the correct imprints are restored later on during germ cell 
development remains unknown. Thirdly, the most infallible method to test full functionality 
of in vitro-derived gametes is to test their ability to fertilize, form a blastocyst and viable 
offspring. In the mouse, this has been tested despite the premature death of offspring 
(Nayernia et al., 2006). One obstacle is how can we overcome ethical boundaries and 
challenges to do similar tests with human gametes? Perhaps for now, the primary medical 
application of human stem cell-derived gametes would be to use them as a reproductive 
toxicological screen for pharmaceutical compounds and other chemicals.  
5. Conclusions 
In the last decade, much progress has been made in our understanding of mouse and 
human embryology and embryonic stem cells. We have learned that complex genetic 
pathways that underlie the pluripotency aspects of hESCs and mESCs also underline our 
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inability to easily control and direct these cells toward a specific lineage. In addition, the 
advent of diverse strategies to ‘reprogram’ somatic cells has opened up an almost limitless 
access to patient-specific stem cells that if used correctly, could provide very powerful cell-
based therapies. Scientifically, the biology of germline development has always been an 
popular area of exploration for embryologists and stem cell biologists, especially because 
germ cells are unique in their ability to transmit genetic information from one generation to 
the next. If we can understand how germ cells develop from ESCs at the cellular and 
molecular level, we can apply this information to the derivation of male and female 
gametes. The goals of gamete formation include: 1) to address immediate health issues such 
as infertility in men and women due to sperm and egg dysfunction or absence; 2) to produce 
gametes that can be fertilized and produce an almost limitless source of mammalian 
embryos and ESCs for the study of specific diseases; 3) to devise methods with which to 
target hereditary and non-hereditary germline mutations or chromosomal abnormalities 
during the earliest stages of germ cell production.  
The studies summarized in this review have shown that multipotent ES-like SSCs can 
develop into somatic cells of all three germ layers, but their ability to differentiate to the 
germline remains unclear or untested. In addition, it is believed that SSCs may only be 
multipotent and will be useful only for autologous transplantation and maybe for only a few 
tissue types. In this regard, one promising avenue for SSCs is differentiation down the 
spermatogenic pathway. Finally, there is a limited expansion potential of SSCs compared to 
iPSCs or hESCs and the imprinting status of these cells is less well defined than that of 
hESCs. A similar approach as used by Kee et al. in 2009 to overexpresss DAZ genes in 
hESCs could potentially be applied to differentiate SSC’s to spermatids or sperm in vitro. 
Alternatively, one could envision that the research on in vitro-derived human oocytes could 
be similarly advanced and lead to a better understanding of the concept that there are 
renewable ovarian stem cells in humans. In conclusion, the potential of ESCs and iPSCs to 
be used for cell-based therapy is now being realized. Major challenges, both scientific and 
clinical, still exist in deriving germline cells that look and behave as reliably as their natural 
counterparts. With further advances in technology and the elucidation of new pathways in 
gerrmline function in the mouse and human systems, we predict that these challenges can 
be met and overcome in the future. 
Keypoints: 
 Mouse and human embryonic stem cells provide the ideal substrate for germline 
differentiation, both in vivo and in vitro. 
 The mammalian germline is established as primordial germ cells immediately prior to 
gastrulation in mice and humans, and undergo similar physiological and molecular 
events. 
 Induced pluripotent stem cells (iPSCs) and adult stem cells may provide alternative 
sources of pluripotent and multipotent stem cells with less potential for host rejection 
and decreased tumorigenicity.  
 Testicular stem cells with multipotent and even pluripotent potential have been isolated 
in mouse models and, more recently, in humans. 
 The in vitro derivation of early male and female germ cells is now achievable from 
mESCs, hESCs and human iPSCs with the application of various reporter systems and 
through embryoid body (EB) formation.  
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